-
Sartorius and TheWell Bioscience Partner to Enable More Accurate Predictions in Drug Discovery
PharmaSources
April 10, 2024
TheWell Bioscience is a pioneer in the field of animal-free hydrogels and bioinks, critical components for the creation of 3D biomimicking platforms.
-
First Study Using Biomimetic AI Digital Twins And Multiomics in Genetics Research
PharmaSources
April 07, 2024
The Application of Knowledge Engineering via the use of a Biomimetic Digital Twin Ecosystem, Phenotype DrivenVariant Analysis, and Exome Sequencing to Understand the Molecular Mechanisms of Disease.
-
University of Liverpool to Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical Study
PharmaSources
April 07, 2024
Touchlight announced an agreement with University of Liverpool for the use of dbDNA in the development of a fully-personalised therapeuticneoantigen DNA vaccine for patients with non-small cell lung cancer.
-
ProBioGen and DIOSynVax Partner to Manufacture Groundbreaking Multivalent Vaccine for Hemorrhagic Fever
PharmaSources
April 01, 2024
ProBioGen’s MVA CR19vector will be used to deliver the three HF vaccine antigens.
-
InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
PharmaSources
April 01, 2024
ICP-189 is a potent and selective oral allosteric inhibitor of SHP2, developed by InnoCare for the treatment of solid tumors as a single agent and/or in combination with other antitumor agents.
-
InnoCare Releases 2023 Results and Business Highlights
PharmaSources
March 29, 2024
InnoCare Pharma, a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2023 annual results as of 31 December 2023.
-
Vetter Earns Prestigious Honors Across All Core Categories in the 13th Annual CDMO Leadership Awards
PharmaSources
March 27, 2024
Vetter once again earned the 2024 CDMO Leadership Awards in all six core categories – quality, expertise, reliability, capabilities, compatibility and service for big pharma, small pharma and overall respondents.
-
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System
PharmaSources
March 27, 2024
Two companies have jointly begun a demonstration experiment of a cloud endoscopy system that enables image processing on the cloud.
-
Avantor Wins Five Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2024
PharmaSources
March 21, 2024
Recognition reinforces Avantor's commitment to innovation and leadership for biopharma advancement.
-
Single Use Support Opens US Office
PharmaSources
March 15, 2024
Fluid and cold chain management expert Single Use Support has opened a subsidiary in Lexington, Massachusetts.